Table 2.
Biochemical factors in biomimetic periosteum fabrication.
Classification | Biochemical elements | Pros | Cons | Ref. |
---|---|---|---|---|
Cells | Osteoblasts | Promote new bone formation; Accelerate bone mineralization |
Insufficient sources, long expansion cycle | [58] |
MSCs | Self-renewal ability; Osteogenesis capacity |
Limited vascularization; | [[74], [75], [76]] | |
Human dermal fibroblasts | Mimic ECM structure | Limited vascularization; | [60] | |
HUVECs | Angiogenesis capacity | Limited osteoinduction; | [77] | |
Growth factors | TGF | Promote collagen production; Anti-inflammation |
High cost; short half-life Possible oncogenesis |
[69] |
PDGF | Promote the proliferation of osteoprogenitor cells | [78] | ||
VEGF | Promote angiogenesis | [74,79,80] | ||
FGF | Promote tissue repair and periosteal chondrogenesis | [[81], [82], [83]] | ||
IGF | Promote fracture healing; Increase the bone mineral density |
[84,85] | ||
BMP | Induce MSC osteogenic differentiation; Promote fracture healing; |
[67,86] | ||
Small biomolecules | Dexamethasone | Promote cell proliferation and bone formation | Difficult to control the dose | [87,88] |
Glycerophosphate | Induce mineralized bone formation | Short drug effect | [89] | |
RGD | Enhance cell adhesion to non-adhesive surfaces | High cost | [90] | |
Icariin | Enhance the proliferation of periosteal cells | Abnormal coagulation | [11,91] |